DiaSorin S.p.A: New DiaSorin S.p.A company profile published
DiaSorin S.p.A. (DiaSorin) is a medical device company. The company undertakes the development and manufacture of reagents pertaining to in-vitro diagnostics and systems that enable automatic diagnostic investigation. Its key product offerings include radio immuno assays (RIA), enzyme linked immunosorbent assays (ELISA) and chemiluminescent immuno assays (CLIA). The company also develops and distributes immune reagent kits for clinical diagnostics and equipment that are to be used in combination with reagents, to facilitate automatic diagnostic investigation. DiaSorin Group operates through 24 companies based in Europe, the US, Central and South America and Asia.
DiaSorin envisages building its position in the marketplace by focusing on key product groups including CLIA product portfolio, Murex product line, Vitamin D market and molecular diagnostics market. It also strives to grow through strategic acquisitions and agreements. The company is headquartered at Saluggia, Vercelli, Italy.
DiaSorin S.p.A Key Recent Developments
Aug 03, 2012: DiaSorin Reports Revenue Of €155m In Q2 2012
May 11, 2012: DiaSorin Reports Revenue Of €105.7m In Q1 2012
Mar 09, 2012: DiaSorin Reports Revenue Of €197.6m In 2011
Dec 19, 2011: DIASORIN LAUNCHES THE FIRST FULLY AUTOMATED ASSAY FOR THE DETECTION OF CLOSTRIDIUM DIFFICILE TOXINS A AND B IN STOOLS
Nov 11, 2011: DiaSorin Reports Revenue Of €105.2m In Q3 2011
This comprehensive SWOT profile of DiaSorin S.p.A provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company's operations and business divisions.
- Corporate strategy – Analyst's summarization of the company's business strategy.
- SWOT Analysis – A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives' employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
DiaSorin S.p.A - Key Facts
DiaSorin S.p.A - Key Employees
DiaSorin S.p.A - Key Employee Biographies
DiaSorin S.p.A - Key Operational Employees
DiaSorin S.p.A - Major Products and Services
DiaSorin S.p.A - Medical Equipment Pipeline Products Data
DiaSorin S.p.A Pipeline Products by Equipment Type
DiaSorin S.p.A Pipeline Products by Development Stage
DiaSorin S.p.A - History
DiaSorin S.p.A - Company Statement
DiaSorin S.p.A - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
DiaSorin S.p.A - Business Description
DiaSorin S.p.A - Corporate Strategy
DiaSorin S.p.A - SWOT Analysis
SWOT Analysis - Overview
DiaSorin S.p.A - Strengths
Strength - Fully Equipped Manufacturing Facilities
Strength - Leading Market Player
Strength - Focused Research and Development Activities
DiaSorin S.p.A - Weaknesses
Weakness - Product Recalls
DiaSorin S.p.A - Opportunities
Opportunity - Regulatory Approval and New Product Launches
Opportunity - Strategic Agreements
Opportunity - Growing IVD Market
DiaSorin S.p.A - Threats
Threat - Changing Diagnostic Market Conditions
Threat - Stringent Government Regulations
Threat - Rapid Technological Changes
DiaSorin S.p.A - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company's Lifesciences Financial Deals and Alliances
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2006 to YTD 2012
DiaSorin S.p.A, Medical Equipment, Deals By Type, 2006 to YTD 2012
DiaSorin S.p.A, Recent Deals Summary
Section 5 – Company's Recent Developments
DiaSorin S.p.A, Recent Developments
03/08/2012: DiaSorin Reports Revenue Of €155m In Q2 2012
30/07/2012: DiaSorin Forms Joint Venture With Trivitron Healthcare
11/05/2012: DiaSorin Reports Revenue Of €105.7m In Q1 2012
04/05/2012: Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For $10 Million
09/03/2012: DiaSorin Reports Revenue Of €197.6m In 2011
02/02/2012: DiaSorin Receives FDA Clearance For Its LIAISON 25 OH Vitamin D TOTAL Assay
12/01/2012: DiaSorin Receives CE Mark Approval For Its New Anti HBs II Assay
19/12/2011: DIASORIN Launches First Fully Automated Assay For Detection Of Clostridium Difficile Toxins A And B In Stools
19/12/2011: DiaSorin Launches First Fully Automated Assay For Detection Of Clostridium Difficile Toxins A And B In Stools
11/11/2011: DiaSorin Reports Revenue Of €105.2m In Q3 2011
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
DiaSorin S.p.A, Key Facts
DiaSorin S.p.A, Key Employees
DiaSorin S.p.A, Key Employee Biographies
DiaSorin S.p.A, Key Operational Employees
DiaSorin S.p.A, Major Products and Services
DiaSorin S.p.A Number of Pipeline Products by Equipment Type
DiaSorin S.p.A Pipeline Products by Equipment Type
DiaSorin S.p.A Number of Pipeline Products by Development Stage
DiaSorin S.p.A Pipeline Products by Development Stage
DiaSorin S.p.A, History
DiaSorin S.p.A, Other Locations
DiaSorin S.p.A, Subsidiaries
DiaSorin S.p.A, Key Competitors
DiaSorin S.p.A, Ratios based on current share price
DiaSorin S.p.A, Annual Ratios
DiaSorin S.p.A, Interim Ratios
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2006 to YTD 2012
DiaSorin S.p.A, Medical Equipment, Deals By Type, 2006 to YTD 2012
DiaSorin S.p.A, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
DiaSorin S.p.A Pipeline Products by Equipment Type
DiaSorin S.p.A Pipeline Products by Development Stage
DiaSorin S.p.A, Performance Chart (2007 - 2011)
DiaSorin S.p.A, Ratio Charts
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2006 to YTD 2012
DiaSorin S.p.A, Medical Equipment, Deals by Type, 2006 to YTD 2012 37